Speakers Tuesday, January 14, 2003 9:00 a.m. PST Live question and answer session with Dr. Altshuler 11:00 a.m. PST Bipolar: Overview, Course and Depression Relapse Prevention Lori L. Altshuler, M.D. Professor Director, Mood Disorders Research Program Department of Psychiatry & Biobehavioral Sciences David Geffen School of Medicine at UCLA Biosketch: Lori Altshuler, M.D. completed her undergraduate and medical training at Cornell University. She came to the UCLA Neuropsychiatric Institute and Hospital to complete her residency in psychiatry. She completed a fellowship at the National Institute of Mental Health under the mentorship of Dr. Robert Post. It was there that she developed her desire to continue studying the course and treatment of bipolar illness as well as developed an interest in the functional neuroanatomic underpinnings of bipolar disorder. Dr. Altshuler currently directs the Mood Disorders Research Program at UCLA. Her major interests include neuroimaging in mood disorders as well as the treatment of bipolar illness and determents of functional recovery in patients who have bipolar illness. Learning Objectives: At the conclusion of this talk the audience should be able to: Understand the course and long-term out come of bipolar illness. Understand the treatment of bipolar depression and prevention of depressive relapse. Tuesday, February 11, 2003 9:00 a.m. PST Live question and answer session with Dr. Manji 11:00 a.m. PST Neurobiology of Bipolar Disorder: Neuroplasticity and Cellular Resilience Husseini K. Manji, M.D., FRCPC Chief Laboratory of Molecular Pathophysiology National Institute of Mental Health Biosketch: Husseini K. Manji, M.D. is Chief, Laboratory of Molecular Pathophysiology, NIMH. Dr. Manji received his B.S. (Biochemistry) and M.D. from the University of British Columbia. Following psychiatry residency training, he subsequently completed fellowship training in psychopharmacology at the NIMH and undertook extensive additional training in Cellular and Molecular Biology at the NIDDK. Learning Objectives: At the conclusion of this talk the audience should be able to: Understand the role of neurotrophic signaling pathways in the mechanisms of action of mood stabilizing agents. Understand the strategies by which novel drugs for manic-depressive illness are being developed. Tuesday, March 11, 2003 9:00 a.m. PST Live question and answer session with Dr. McElroy 11:00 a.m. PST New Treatments in Mania Susan McElroy, M.D. Professor of Psychiatry Co-Director of Psychopharmacology Research Director Obesity Treatment and Research University of Cincinnati College of Medicine Biosketch: Susan L. McElroy received her M.D. from Cornell University Medical School. Following her residency in Internal Medicine at Columbia Presbyterian Hospital, New York, she completed a residency in Psychiatry at McLean Hospital in Belmont, Massachusetts, where she was a Clinical Fellow in Psychiatry at Harvard Medical School. Dr. McElroy served as Director of the Psychopharmacologic Services, Adult Outpatient Clinic at McLean Hospital from 1988-1991 and was an Assistant Professor of Psychiatry at Harvard Medical School. Learning Objectives: At the conclusion of this talk the audience should be able to: Understand and review recent studies of new medications, particularly anticonvulsants and atypical antipsychotics, in the treatment of acute mania. Understand and review recent studies of new strategies (monotherapy vs combination therapy) in the treatment of acute mania. Tuesday, April 15, 2003 9:00 a.m. PST Live question and answer session with Dr. Suppes 11:00 a.m. PST Bipolar II Disorder: The Concept of Dysphoric Hypomania Trisha Suppes, M.D., Ph.D. Associate Professor, Department of Psychiatry Director of Bipolar Disorder Clinic and Research Program UT Southwestern Medical Center Biosketch: Trisha Suppes, MD, PhD, is Associate Professor in the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas. In addition, she is Director of the Bipolar Disorder Clinic and Research Program at the University of Texas Southwestern Medical Center and Director of the Bipolar Disorder Module for the Texas Algorithm Medication Project. Learning Objectives: At the conclusion of this talk the audience should be able to: Understand and be able to differentially diagnose Bipolar II Disorder from other psychiatric illnesses. Understand how dysphoric hypomanic symptoms may present and know the frequency these symptoms occur for patients experiencing hypomanic symptoms.